Although we did not observe a reduction in Mtb CFUs or pathology with MET treatment, we saw remarkable improvements in CD8+ T cell bioenergetics at D35 post-infection that corresponded with a decreased inflammatory profile. The gene discussed is CD8A; the disease is infection.